StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Accrued Investment Income Receivable by Quarter

Accrued Investment Income Receivable ($M)

QuarterlyAnnual

Elevance Health Accrued Investment Income Receivable: $308M in Q3 2026, up 10.0% from a year earlier.

Latest, Q3 2026
308
Period ended Sep 30, 2026
Change on a year earlier
+10.0%
280 in Q3 2025
History
47 quarters
Since Q1 2015
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“us-gaap:AccruedInvestmentIncomeReceivable (2026-09-30): 308,000,000.00”

Source: ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccrued Investment Income Receivable ($M)Year on yearSource
Q3 2026Sep 30, 2026308+10.0%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q2 2026Jun 30, 2026322+13.4%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q1 2026Mar 31, 2026299+11.6%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q4 2025Dec 31, 2025295+2.8%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q3 2025Sep 30, 2025280-6.7%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q2 2025Jun 30, 2025284-10.1%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q1 2025Mar 31, 2025268-8.8%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q4 2024Dec 31, 2024287-4.7%ELV 10-K (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q3 2024Sep 30, 2024300+6.8%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q2 2024Jun 30, 2024316+18.8%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q1 2024Mar 31, 2024294+14.8%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q4 2023Dec 31, 2023301+22.9%ELV 10-K (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q3 2023Sep 30, 2023281+23.2%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q2 2023Jun 30, 2023266+25.5%ELV 10-Q/A (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q1 2023Mar 31, 2023256+38.4%ELV 10-Q (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗
Q4 2022Dec 31, 2022245+19.5%ELV 10-K (XBRL us-gaap:AccruedInvestmentIncomeReceivable) ↗

Cite this data

StockData. (2026). Elevance Health Accrued Investment Income Receivable ($M), quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv-accrued-investment-income

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.